Annoviant
Pre-clinicalTxGuard™ is a patented, regenerative tissue innovation that heals and grows with the patient.
Founded
2015
Focus
CardiovascularMedical Devices
About
TxGuard™ is a patented, regenerative tissue innovation that heals and grows with the patient.
Funding History
9Total raised: $41.7M
Grant$833KNHLBIMar 22, 2024
Grant$1.0MNHLBIJul 28, 2022
Series A$18.3MJohnson & Johnson InnovationJul 15, 2022
Grant$818KNHLBISep 20, 2021
Company Info
TypePrivate
Founded2015
LocationMadison, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile